<DOC>
	<DOCNO>NCT02844153</DOCNO>
	<brief_summary>Metformin widely prescribe oral treatment diabetes , one show survival benefit . Yet , consensus optimal dose withdrawal metformin chronic kidney disease ( CKD ) patient . The aim study describe use side-effects metformin CKD patient routine practice .</brief_summary>
	<brief_title>Metformin Use Chronic Kidney Disease : The CKD-Met Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>18 year old Type 2 diabetes Seen nephrologist ( consultation hospitalization ) March 2014 March 2020 Department Nephrology , Lyon Sud university hospital , France Ongoing treatment dialysis Kidney transplantation Type 1 diabetes Missing data ( metformin treatment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Metformin</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>antidiabetic medication</keyword>
	<keyword>lactic acidosis</keyword>
</DOC>